Carcinoid tumor of thymus
ICD-10 C37 · ICD-11 2C27.1

Carcinoid Tumor of Thymus in Cushing's Syndrome due to Ectopic ACTH Secretion

Clinical Scenario

This protocol addresses thymic carcinoid presenting with Cushing's syndrome caused by ectopic adrenocorticotropic hormone (ACTH) secretion. Ectopic ACTH-driven Cushing's syndrome is the most frequent functional syndrome encountered in thymic carcinoid.

The co-occurrence of Cushing's syndrome from ectopic ACTH secretion substantially shapes the clinical priorities. Managing cortisol excess is a central consideration alongside tumour-directed care.

Management Approach (partial)

When Cushing's syndrome becomes refractory in this setting, surgical intervention is among the options addressed in the full protocol — alongside selected pharmacological strategies targeting cortisol excess. The complete evidence-based regimen, decision criteria, and sequencing are available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.annonc.2021.01.003

CuS caused by ectopic ACTH secretion is the most frequent functional syndrome in ThC.

In patients with refractory CuS, early bilateral adrenalectomy should be considered [IV, B]

View source ↗